由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Biology版 - 4个包子求paper
相关主题
请问一下哪个VEGFR2的抗体比较好用Paper Help!
some biology research journal IFspaper help,thanks
Top120 Scientific Journals (ISI 2003)[讨论]免疫学杂志的档次分类
求文章Journal求助:Nature系列投哪个好?
paper wanted thanks a lot!* 求文献 *
求文章,多谢跪求两篇文章~
急求2篇paper! thanks !!!!!paper help please
paper help, thanks撤稿造假第一名是印度,中国位居第二
相关话题的讨论汇总
话题: wakatsuki话题: pubmed话题: yoshiji话题: clin话题: immunol
进入Biology版参与讨论
1 (共1页)
m*******5
发帖数: 45
1
Clin Exp Immunol. 2013 Jun;172(3):500-6. doi: 10.1111/cei.12069.
Simultaneous blockade of programmed death 1 and vascular endothelial growth
factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo.
Yasuda S, Sho M, Yamato I, Yoshiji H, Wakatsuki K, Nishiwada S, Yagita H,
Nakajima Y.
PMID:
23600839
[PubMed - in process]
email, m********[email protected]
thanks a lot.
s****9
发帖数: 932
2
Sent to your email box.

growth

【在 m*******5 的大作中提到】
: Clin Exp Immunol. 2013 Jun;172(3):500-6. doi: 10.1111/cei.12069.
: Simultaneous blockade of programmed death 1 and vascular endothelial growth
: factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo.
: Yasuda S, Sho M, Yamato I, Yoshiji H, Wakatsuki K, Nishiwada S, Yagita H,
: Nakajima Y.
: PMID:
: 23600839
: [PubMed - in process]
: email, m********[email protected]
: thanks a lot.

m*******5
发帖数: 45
3
baozi sent. thanks a lot.

【在 s****9 的大作中提到】
: Sent to your email box.
:
: growth

1 (共1页)
进入Biology版参与讨论
相关主题
撤稿造假第一名是印度,中国位居第二paper wanted thanks a lot!
文献求助!求文章,多谢
paper help!!!!急求2篇paper! thanks !!!!!
paper help!!!!paper help, thanks
请问一下哪个VEGFR2的抗体比较好用Paper Help!
some biology research journal IFspaper help,thanks
Top120 Scientific Journals (ISI 2003)[讨论]免疫学杂志的档次分类
求文章Journal求助:Nature系列投哪个好?
相关话题的讨论汇总
话题: wakatsuki话题: pubmed话题: yoshiji话题: clin话题: immunol